LONDON - Britain’s medicines regulator said there had been five cases of a rare type of blood clot in the brain among 11 million given AstraZeneca’s COVID-19 vaccine but said that it found the benefits of the shot far outweigh any possible risks.
However, Britain’s Medicines and Healthcare products Regulatory Agency said that use of the vaccine should continue while five reports were investigated, and one official said that the rollout would likely continue even if a link was proved. “Given the extremely rare rate of occurrence of these CSVT events among the 11 million people vaccinated , and as a link to the vaccine is unproven, the benefits of the vaccine in preventing COVID-19, with its associated risk of hospitalisation and death, continue to outweigh the risks of potential side effects,” she said.
Munir Pirmohamed, Chair of the Commission on Human Medicines, in a statement suggested that even if a link between the clots and the vaccine was established, it likely wouldn’t halt Britain’s rollout.
Even if causal affect was proven..this is clot per every 2 million people vaccinated. My wife and I took and no issues whatsiever
War of vaccines
News sponsored by Pfizer.